Search results
Results from the WOW.Com Content Network
Botulinum toxin therapy of strabismus is a medical technique used sometimes in the management of strabismus, in which botulinum toxin is injected into selected extraocular muscles in order to reduce the misalignment of the eyes. The injection of the toxin to treat strabismus, reported upon in 1981, is considered to be the first ever use of ...
In December 1989, Botox was approved by the US FDA for the treatment of strabismus, blepharospasm, and hemifacial spasm in people over 12 years old. [107] In the case of treatment of infantile esotropia in people younger than 12 years of age, several studies have yielded differing results. [56] [151]
The condition of a dog's skin and coat is also an important indicator of its general health. Skin disorders of dogs vary from acute, self-limiting problems to chronic or long-lasting problems requiring life-time treatment. Skin disorders may be primary or secondary (due to scratching, itch) in nature, making diagnosis complicated.
The One Look a Pet Behaviorist Is Begging Dog Owners to Start Noticing in Their Pup's Body Language. Shelby Deering. August 14, 2024 at 7:10 PM. iStock. While humans certainly display their fair ...
However, Dolce & Gabbana has made a new perfume for dogs, called Fefé, in honor of Domenico Dolce’s poodle. It’s alcohol-free, but it’s divided vets and dog parents, with not everyone being ...
Alan B. Scott. Alan Brown Scott (July 13, 1932 – December 16, 2021 [1]) was an American ophthalmologist specializing in eye muscles and their disorders, such as strabismus (eye misalignment). He is best known for his work in developing and manufacturing the drug that became known as Botox, research described as "groundbreaking" by the ASCRS. [2]
The management of strabismus may include the use of drugs or surgery to correct the strabismus. Agents used include paralytic agents such as botox used on extraocular muscles, [1] topical autonomic nervous system agents to alter the refractive index in the eyes, and agents that act in the central nervous system to correct amblyopia. [2]
Clostridium botulinum is a gram-positive, [ 1] rod-shaped, anaerobic, spore-forming, motile bacterium with the ability to produce botulinum toxin, which is a neurotoxin. [ 2][ 3] C. botulinum is a diverse group of pathogenic bacteria. Initially, they were grouped together by their ability to produce botulinum toxin and are now known as four ...